LUCD
Lucid Diagnostics Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- B May 20 1 insider buy $245.3K at $1.00
- R Oct 16 Lucid Diagnostics received a Nasdaq deficiency notice on October 12,…
- R Oct 22 Lucid Diagnostics raised $15.0 million via a private placement of 15…
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $245.3K at an average $1.00. No open-market sales. Price is 50% below their cost.
- InstitutionsBULLISH
Q2 2026: 34 added (0 new), 4 trimmed or exited.
- AnalystsBULLISH
10 of 11 rate it Buy or better.
- EstimatesFALLING
Current-quarter EPS estimate −$0.055 → −$0.057 over 90 days. 0 up, 1 down in 30 days.
- TrendDOWNTREND
34% below its 50-day average. New closing low $0.3280 on Oct 22.
- SocialQUIET
Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $9.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | ADD | $7.0M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $4.1M |
| STATE STREET CORP | ADD | $2.6M |
| FIRST MANHATTAN CO. LLC. | DOUBLED | $2.3M |
| WELLS FARGO & COMPANY/MN | ADD | $2.2M |
| NORTHERN TRUST CORP | ADD | $1.3M |
| VANGUARD FIDUCIARY TRUST CO | ADD | $1.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analysts| Date | Firm | Rating |
|---|---|---|
| Oct 23, 2026 | BTIG REITERATE | Buy |
| Aug 27, 2026 | Ascendiant Capital MAINTAIN | Buy |
| Aug 17, 2026 | BTIG REITERATE | Buy |
| Jun 8, 2026 | Ascendiant Capital MAINTAIN | Buy |
| May 15, 2026 | Maxim Group MAINTAIN | Buy |
| May 15, 2026 | BTIG REITERATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Matheis Dennis Director | BUY | $245.3K |
| Feb 20, 2026 | Cox James L Director | AWARD | 123,000 sh |
| Feb 20, 2026 | White Debra Director | AWARD | 123,000 sh |
| Feb 20, 2026 | Matheis Dennis Director | AWARD | 123,000 sh |
| Feb 20, 2026 | PALUMBO JOHN R Director | AWARD | 123,000 sh |
| Feb 20, 2026 | Gordon Michael Adam General Counsel and Secretary | AWARD | 300,000 sh |
| Feb 20, 2026 | O'Neil Shaun President and COO | AWARD | 620,000 sh |
| Feb 20, 2026 | SOKOLOV JACQUE J Director | AWARD | 123,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.06 | -$0.06–-$0.05 | -7.9% | $1.6M |
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | -$0.24 | -$0.25–-$0.24 | -2.8% | $6.3M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
7 filings · 1 bullish · 3 bearish · 1 mixed · 2 neutral- BEARISH 8-KOct 22, 2026
Lucid Diagnostics raised $15.0 million via a private placement of 15,000 shares of newly created…
Massive potential dilution from the $0.3519 conversion price and 20% PIK dividend creates a strong downward overhang on LUCD common stock. Monitor for early conversion activity and the filing of the…
- BEARISH 8-KOct 16, 2026
Lucid Diagnostics received a Nasdaq deficiency notice on October 12, 2026, for failing to maintain…
Monitor for any reverse stock split or capital raise announcement as the most likely path to regain compliance before the April 12, 2027 deadline. The stock's continued decline below $1.00 increases…
- BULLISH 8-KSep 22, 2026
Lucid Diagnostics announced three regulatory advances for its EsoGuard test and EsoCheck device: a…
Monitor CMS's final determination in November on EsoGuard's gapfill payment basis and the effective date of the new Category III CPT code. The start of Medicare claims submission at the Texas…
- MIXED 8-KAug 13, 2026
Lucid Diagnostics reported Q2 2026 revenue of $1.5M, up 27% YoY from $1.2M, and processed 2,770…
The commercial coverage policy win is a tangible step toward reimbursement, but the widening loss and lack of guidance keep the risk/reward balanced. Monitor the upcoming Medicare coverage decision…
All LUCD filing & press-release reports (7)
- 8-K reportOct 22, 2026
- 8-K reportOct 16, 2026
- 8-K reportSep 22, 2026
- 8-K reportAug 13, 2026
- 8-K reportMay 14, 2026
- 8-K reportApr 24, 2026
- 8-K reportApr 23, 2026